Blmh - bleomycin hydrolase Gene
Species: Rattus norvegicus
Gene Type: protein coding
Gene ID: 287552
Summary
Predicted to enable Aminopeptidase activity; cysteine-type peptidase activity; and identical protein binding activity. Predicted to be involved in homocysteine catabolic process and response to toxic substance. Predicted to act upstream of or within response to xenobiotic stimulus. Predicted to be active in cytoplasm. Orthologous to human BLMH (bleomycin hydrolase). [provided by Alliance of Genome Resources, Apr 2022]
Blmh Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_001034163.1 | NP_001029335.1 | bleomycin hydrolase |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
bleomycin hydrolase |
|
|
Related Agents
- Pre-clinical Phase
Pre-clinical Phase
Bioactive Molecules
(3)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-RS01521 | BLMH Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS18230 | Blmh Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS24709 | Blmh Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service